Brief report| Volume 30, ISSUE 10, P1056-1058, November 15, 1991

Download started.


Platelet 3H-imipramine and 3H-paroxetine binding during treatment with psychoactive drugs

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Marshall E.F.
        • Tyrer S.P.
        • Alderson E.
        • Eccleston D.
        Effects of fluoxetine on imipramine binding in vivo and in vitro.
        Br J Pharmacol. 1985; : 351
        • Mellerup E.T.
        • Plenge P.
        Imipramine binding in depression and other psychiatric conditions.
        Acta Psychiatr Scand. 1988; 78: 61-68
        • Mellerup E.T.
        • Plenge P.
        Why some depressed patients may have low platelet 3H-imipramine binding.
        Acta Psychiatr Scand. 1990; 82: 330-334
        • Poirier M.F.
        • Loo H.
        • Sechter D.
        • et al.
        3H-imipramine binding and 3H-5HT uptake in human blood platelets: Changes after one week chlorimipramine treatment.
        Eur J Pharmacol. 1984; 106: 629-633